Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)

SHA:688443 Statistics

Total Valuation

SHA:688443 has a market cap or net worth of CNY 10.58 billion. The enterprise value is 9.31 billion.

Market Cap	10.58B
Enterprise Value	9.31B

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

SHA:688443 has 366.68 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	366.68M
Shares Outstanding	366.68M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.67%
Owned by Insiders (%)	5.91%
Owned by Institutions (%)	11.06%
Float	113.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	46.98
PB Ratio	5.92
P/TBV Ratio	6.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-15.95
EV / Sales	41.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.39

Financial Position

The company has a current ratio of 7.59, with a Debt / Equity ratio of 0.59.

Current Ratio	7.59
Quick Ratio	7.07
Debt / Equity	0.59
Debt / EBITDA	n/a
Debt / FCF	-2.18
Interest Coverage	-20.10

Financial Efficiency

Return on equity (ROE) is -28.18% and return on invested capital (ROIC) is -13.20%.

Return on Equity (ROE)	-28.18%
Return on Assets (ROA)	-12.42%
Return on Invested Capital (ROIC)	-13.20%
Return on Capital Employed (ROCE)	-23.17%
Revenue Per Employee	303,045
Profits Per Employee	-785,359
Employee Count	743
Asset Turnover	0.07
Inventory Turnover	0.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.24% in the last 52 weeks. The beta is 0.81, so SHA:688443's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	+18.24%
50-Day Moving Average	28.11
200-Day Moving Average	29.98
Relative Strength Index (RSI)	48.75
Average Volume (20 Days)	3,835,742

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688443 had revenue of CNY 225.16 million and -583.52 million in losses. Loss per share was -1.59.

Revenue	225.16M
Gross Profit	209.30M
Operating Income	-628.51M
Pretax Income	-583.52M
Net Income	-583.52M
EBITDA	-568.67M
EBIT	-628.51M
Loss Per Share	-1.59

Balance Sheet

The company has 2.32 billion in cash and 1.05 billion in debt, with a net cash position of 1.27 billion or 3.46 per share.

Cash & Cash Equivalents	2.32B
Total Debt	1.05B
Net Cash	1.27B
Net Cash Per Share	3.46
Equity (Book Value)	1.79B
Book Value Per Share	4.88
Working Capital	2.19B

Cash Flow

In the last 12 months, operating cash flow was -414.12 million and capital expenditures -65.91 million, giving a free cash flow of -480.03 million.

Operating Cash Flow	-414.12M
Capital Expenditures	-65.91M
Free Cash Flow	-480.03M
FCF Per Share	-1.31

Margins

Gross margin is 92.95%, with operating and profit margins of -279.14% and -259.16%.

Gross Margin	92.95%
Operating Margin	-279.14%
Pretax Margin	-259.16%
Profit Margin	-259.16%
EBITDA Margin	-252.56%
EBIT Margin	-279.14%
FCF Margin	n/a

Dividends & Yields

SHA:688443 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	-5.52%
FCF Yield	-4.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:688443 has an Altman Z-Score of 4.02 and a Piotroski F-Score of 3.

Altman Z-Score	4.02
Piotroski F-Score	3